SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Centocor ( CNTO ) -- Ignore unavailable to you. Want to Upgrade?


To: PawPr who wrote (610)3/31/1998 1:55:00 PM
From: Norm Demers  Respond to of 965
 
Has anybody seen this yet ?

newsalert.com



To: PawPr who wrote (610)4/2/1998 10:08:00 AM
From: FNS  Read Replies (2) | Respond to of 965
 
Bruce et al: CNTO takes a big hit in opening due to approval of COR's drug....coming back a little but am queezy as to how much it'll recover. Need to do some research on Cor's drug. As I recall the previous application announcement also stung CNTO. ReopRro now to have some competition but perhaps ReoPro will be drug of choice, but cost of ReoPro may be a negative!

Any comments?

FNS